The Role of Environmental Toxins (Rotenone) in Parkinson’s Disease
Objective: Learn the role of environmental toxins - rotenone in development of Parkinson's disease Background: Rotenone is a powerful pesticide. It is also a lipophilic…The Influence of Sociodemographic Factors on Post-DBS Impulse Control Symptom Severity in Parkinson’s Disease
Objective: To develop a model to predict changes in impulse control symptom severity (ICSS) following deep brain stimulation (DBS) in patients with Parkinson’s disease (PD).…The social interaction in patients with Parkinson’s disease from the points of activities of daily living and motor function
Objective: To investigate how the social interaction relates to activities of daily living (ADL) and motor function in patients with Parkinson’s disease (PD). Background: In…Functional connectome in Parkinson’s disease mild cognitive impairment
Objective: To unravel functional connectivity (FC) traits in Parkinson’s disease mild cognitive impairment (PD-MCI). Background: PD-MCI is a well-known risk factor for PD associated dementia.…Frequency-dependent abnormalities of intrinsic brain activity in Parkinson´s disease
Objective: The study objective was to assess the changes in amplitude of low frequency fluctuations (ALFF) in patients with Parkinson´s disease (PD) as compared to…Mitochondrial Complex 1, Sigma 1 Receptor and Synaptic Vesicle protein 2A density in early de novo patients with Parkinson’s Disease: pilot PET data
Objective: In this study, we evaluated the density of Mitochondrial complex 1 (MC1), sigma 1 receptor (s1R) and Synaptic Vesicle protein 2A (SV2A) in early…The role of Synaptic vesicle protein 2A (SV2A) in patients with Parkinson’s disease dementia and Dementia with Lewy bodies: An in vivo [11C]UCB-J PET study
Objective: We aimed to investigate the role of synaptic vesicle glycoprotein 2A (SV2A) in Parkinson’s disease dementia (PDD) and Dementia with Lewy bodies (DLB) using…STN deep brain stimulation can directly suppress levodopa-induced dyskinesia in Parkinson’s disease
Objective: The study aims to evaluate the effect of bilateral STN-DBS on levodopa-induced peak-dose dyskinesia in patients with PD. Background: Dyskinesia is among the most…A Real-world Assessment of Hospitalizations Due to Falls among Patients with and without OFF episodes in Parkinson’s Disease
Objective: To investigate the association between “OFF” episodes and hospitalizations due to falls among patients with Parkinson’s disease (PD) in a real-world setting. Background: Quantitative…Artisanal formulations of Cannabis in Movement Disorders. The real-life perspective in a population from Buenos Aires, Argentina. Preliminary report
Objective: To describe the effect of artisanal formulations of CBDo in a retrospective case series of patients with a variable spectrum of movement disorders, who…
- « Previous Page
- 1
- …
- 196
- 197
- 198
- 199
- 200
- …
- 388
- Next Page »